Figure 5. Rate of reported confirmed gonorrhoea cases per 100 000 population, EU/EEA countries reporting consistently, 2005−2014
Table 1: Number and rate of reported confirmed gonorrhoea cases per 100 000 population, EU/EEA, 2010–2014
The surveillance of gonococcal antimicrobial susceptibility surveillance in Europe is essential for detecting emerging and increasing antimicrobial resistance and making quality-assured data available to inform revisions of treatment guidelines.
Assessing the burden of key infectious diseases affecting migrant populations in the EU/EEA
Travel-associated gonorrhoea in four Nordic countries, 2008 to 2013
WGS analysis and molecular resistance mechanisms of azithromycin-resistant (MIC >2 mg/L) Neisseria gonorrhoeae isolates in Europe from 2009 to 2014
Is the tide turning again for cephalosporin resistance in Neisseria gonorrhoeae in Europe? Results from the 2013 European surveillance